Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Multiomics Tumor Evolution Model of NSCLC
- Status
- RECRUITING
- Phase
- N/A
SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit
- Status
- COMPLETED
- Phase
- NA
Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit
- Status
- COMPLETED
- Phase
- NA
Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
- Status
- COMPLETED
- Phase
- N/A
Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1/2 Study of BPI-361175 in Subjects With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Tarlox and Sotorasib in Patients With KRAS G12C Mutations
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment
- Status
- RECRUITING
- Phase
- NA
Combining Afatinib and Concurrent Chemotherapy, Followed by Osimertinib and Concurrent Chemotherapy, in Untreated EGFR Positive NSCLC Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
- Status
- COMPLETED
- Phase
- N/A
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2